These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2991150)

  • 1. The parenteral kinetics of ampicillin/sulbactam in man.
    Foulds G; Knirsch AK; Stankewich JP; Weidler DR
    Int J Clin Pharmacol Res; 1985; 5(2):79-86. PubMed ID: 2991150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasma kinetics of sulbactam-ampicillin administered to calves by the intramuscular and subcutaneous routes.
    Grimshaw WT; Colman PJ
    Br Vet J; 1987; 143(4):361-8. PubMed ID: 3040163
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of sulbactam/ampicillin in humans: a review.
    Foulds G
    Rev Infect Dis; 1986; 8 Suppl 5():S503-11. PubMed ID: 3025997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary pharmacokinetics of sulbactam plus ampicillin in humans.
    Morris DL; Ubhi CS; Robertson CS; Brammer KW
    Rev Infect Dis; 1986; 8 Suppl 5():S589-92. PubMed ID: 3026008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of sulbactam and ampicillin intravenously applied in combination to healthy volunteers and patients. Determination of the ratio of the two drugs in serum and in various tissues.
    Wildfeuer A; Schwiersch U; Engel K; von Castell E; Schilling A; Potempa J; Lenders H
    Arzneimittelforschung; 1988 Nov; 38(11):1640-3. PubMed ID: 3214451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.
    Brown RM; Wise R; Andrews JM; Hancox J
    Antimicrob Agents Chemother; 1982 Apr; 21(4):565-7. PubMed ID: 6282211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of sulbactam in humans.
    Foulds G; Stankewich JP; Marshall DC; O'Brien MM; Hayes SL; Weidler DJ; McMahon FG
    Antimicrob Agents Chemother; 1983 May; 23(5):692-9. PubMed ID: 6307133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampicillin/sulbactam (Unasyn).
    Med Lett Drugs Ther; 1987 Aug; 29(747):79-81. PubMed ID: 3039328
    [No Abstract]   [Full Text] [Related]  

  • 9. [Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral formulations as well as in body fluids and tissue homogenates. Comparison of sulbactam, clavulanic acid, ampicillin and amoxicillin].
    Wildfeuer A; Räder K
    Arzneimittelforschung; 1991 Jan; 41(1):70-3. PubMed ID: 2049115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to neonatal calves.
    Fernández-Varón E; Escudero-Pastor E; Cárceles-Rodríguez CM
    Vet J; 2005 May; 169(3):437-43. PubMed ID: 15848786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration of sulbactam and ampicillin in serum and the myometrium.
    Schwiersch U; Lang N; Wildfeuer DA
    Drugs; 1986; 31 Suppl 2():26-8. PubMed ID: 3013570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of sulbactam and ampicillin in mice and in dogs.
    Liu CX; Wang JR; Lu YL
    Yao Xue Xue Bao; 1990; 25(6):406-11. PubMed ID: 2284964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-mediated resistance to beta-lactam antibiotics: a symposium on sulbactam/ampicillin. Cairo, Egypt, April 18-19, 1985.
    Rev Infect Dis; 1986; 8 Suppl 5():S465-650. PubMed ID: 3025995
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulbactam kinetics and excretion into breast milk in postpartum women.
    Foulds G; Miller RD; Knirsch AK; Thrupp LD
    Clin Pharmacol Ther; 1985 Dec; 38(6):692-6. PubMed ID: 2998677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.
    ROgers HJ; Bradbrook ID; Morrison PJ; Spector RG; Cox DA; Lees LJ
    J Antimicrob Chemother; 1983 May; 11(5):435-45. PubMed ID: 6307964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-agent therapy for acute pelvic inflammatory disease: sulbactam/ampicillin versus cefoxitin.
    Hemsell DL; Bawdon RE; Hemsell PG; Nobles BJ; Heard MC
    J Int Med Res; 1990; 18 Suppl 4():85D-89D. PubMed ID: 2282973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic study of sulbactam and ampicillin administered concomitantly by intraarterial or intravenous infusion in the newborn.
    Sutton AM; Turner TL; Cockburn F; McAllister TA
    Rev Infect Dis; 1986; 8 Suppl 5():S518-22. PubMed ID: 3025999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.
    Houang ET; Colley N; Chapman M
    Antimicrob Agents Chemother; 1985 Jul; 28(1):165-6. PubMed ID: 2994556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.